apollo
logo
0Login
Introducing Our Latest Arrival!
Etimark 0.25 Tablet 10's

Etimark 0.25 Tablet 10's

Not for online sale
Prescription drug
 Trailing icon
Consult Doctor

Composition

ETIZOLAM-0.25MG

Manufacturer/Marketer

Unimarck Pharma India Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-25

for this medicine

About Etimark 0.25 Tablet

Etimark 0.25 Tablet is used in the treatment of anxiety disorder, panic disorder and insomnia (difficulty in falling or staying asleep). Anxiety is a mental health disorder associated with fear, worry and excessive nervousness. Insomnia is a disorder of sleep that causes difficulty in falling asleep or staying asleep. Panic disorder is a type of anxiety disorder that causes sudden feelings of fear even when there is no real danger, with symptoms like a fast heartbeat.

Etimark 0.25 Tablet reduces anxiety/panic, induce sleep, and relaxes muscles due to fit episodes. It works by increasing the activity of GABA (a chemical messenger in the brain that acts as a natural nerve-calming agent) and is involved in inducing sleep. Thereby, Etimark 0.25 Tablet relaxes muscles, reduces anxiety and helps to fall asleep.

Take Etimark 0.25 Tablet as prescribed. Your doctor will advise how often you take Etimark 0.25 Tablet based on your medical condition. The most common side effects of Etimark 0.25 Tablet include drowsiness, ataxia (neurological conditions which affect balance and coordination), dysarthria (difficulty speaking), nystagmus (involuntary eye movement) and blepharospasm (involuntary closure of eyelids). Most of these side effects of Etimark 0.25 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are known to be allergic to Etimark 0.25 Tablet or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, inform your doctor before taking Etimark 0.25 Tablet . Etimark 0.25 Tablet should be used with caution in elderly patients as there is an increased risk of adverse reactions such as dizziness, muscle weakness and drowsiness. Do not take Etimark 0.25 Tablet with opioids as it may cause breathing problems or other severe adverse effects. Respiratory depressant effects of Etimark 0.25 Tablet are life-threatening in patients with severe chronic obstructive airway disease (COPD) and asthma. Overdose may lead to rhabdomyolysis (the breakdown of muscle tissue) and hypothermia (a dangerous drop in body temperature). Alcohol consumption with Etimark 0.25 Tablet may potentiate the toxic effect of the drug.

Uses of Etimark 0.25 Tablet

Treatment of Anxiety disorder, Panic disorder, Insomnia (sleep disorder).

Medicinal Benefits

Etimark 0.25 Tablet is an anxiolytic drug (reduces anxiety) that is used to treat anxiety, panic disorder over a short period and insomnia (difficulty in falling or staying asleep). Etimark 0.25 Tablet increases the activity of GABA (a chemical messenger in the brain that acts as a natural nerve-calming agent) and is involved in inducing sleep. Thereby, Etimark 0.25 Tablet relaxes muscles, reduces anxiety and helps to fall asleep.

Directions for Use

Tablet: Take it with or without food as advised by the doctor. Swallow it as a whole with a glass of water. Do not break, crush or chew it. Tablet MD: Take it with or without food as advised by the doctor. Do not handle the tablet with wet hands. Put it in your mouth and allow it to dissolve slowly. Do not swallow the tablet.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Etimark 0.25 Tablet

  • Drowsiness
  • Ataxia (neurological conditions which affect balance and coordination)
  • Dysarthria (difficulty speaking)
  • Nystagmus (involuntary eye movement)
  • Blepharospasm (involuntary closure of eyelids)

Drug Warnings

Do not take Etimark 0.25 Tablet if you are pregnant or breastfeeding as it may cause adverse effects in the baby. Etimark 0.25 Tablet should be used with caution in elderly patients as there is an increased risk of adverse reactions such as dizziness, muscle weakness and drowsiness. Inform your doctor if you have myasthenia gravis (muscle weakness), chronic pulmonary insufficiency, drug addiction, kidney or liver problems before taking Etimark 0.25 Tablet . Do not take Etimark 0.25 Tablet with opioids as it may cause breathing problems, drowsiness, coma and even death.

Drug Interactions

Drug-Drug Interaction: Etimark 0.25 Tablet may have interaction with high blood pressure-lowering medicines (clonidine, moxonidine, lofexidine, hydralazine, minoxidil, nitroprusside), fits related drugs (phenytoin, clonazepam, carbamazepine), antidepressants (paroxetine, fluvoxamine, trazodone), opioid pain killers (bupropion, morphine, codeine), drugs used to treat heartburn (cisapride), sedative-hypnotics (zolpidem), drugs used to treat low blood sugar (diazoxide), antifungals (fluconazole), drugs for stomach ulcers (cimetidine, esomeprazole, omeprazole), antipsychotics (clozapine), drugs to treat chronic alcoholism (disulfiram).

Drug-Food Interaction: Etimark 0.25 Tablet may interact with alcohol. Therefore, avoid intake of alcohol while taking Etimark 0.25 Tablet as it may increase side effects such as drowsiness, dizziness or difficulty in concentrating.

Drug-Disease Interaction: If you have myasthenia gravis (muscle weakness), pulmonary insufficiency, kidney or liver problems, inform your doctor before taking Etimark 0.25 Tablet .

Drug-Drug Interactions Checker List

  • CLONIDINE
  • MOXONIDINE
  • MINOXIDIL
  • CLONAZEPAM
  • CARBAMAZEPINE
  • PAROXETINE
  • BUPROPION
  • CODEINE
  • ZOLPIDEM
  • FLUCONAZOLE
  • CIMETIDINE
  • ESOMEPRAZOLE
  • OMEPRAZOLE
  • CLOZAPINE
  • DISULFIRAM
  • LOFEXIDINE
  • HYDRALAZINE
  • NITROPRUSSIDE
  • FLUVOXAMINE
  • TRAZODONE
  • MORPHINE
  • CISAPRIDE
  • DIAZOXIDE
  • PHENYTOIN

Habit Forming

Yes

Diet & Lifestyle Advise

  • Do regular exercise and maintain healthy body weight.

  • Maintain a diet rich in fruits, vegetables and whole grains. Avoid fried foods, high-fat dairy products, pastries and processed foods as they may worsen anxiety.

  • Follow a regular sleep pattern. Do not take a nap during day time.

  • Avoid watching tv, using mobiles or laptops just before bedtime.

  • Avoid consumption of alcohol as it may increase drowsiness.

Special Advise

Do not take Etimark 0.25 Tablet for a prolonged time as it may lead to mental or physical dependence on Etimark 0.25 Tablet .

Disease/Condition Glossary

Anxiety: It is a mental health disorder associated with fear, worry and excessive nervousness that may interfere with one’s daily activities. The symptoms of anxiety include feeling more stress than required for that event and a lack of ability to set aside restlessness and worry.

Insomnia: It is a disorder of sleep that causes difficulty in falling asleep or staying asleep. It may be acute (short-term) or chronic (long-term). Acute insomnia may last from one night to a few weeks and occurs due to stress or life changes. Chronic insomnia may last from more than 3 nights per week to more than 3 months. Insomnia is mostly caused by depression, stress, anxiety, jet lag, shift work, uncomfortable beds, chronic illness, caffeine, nicotine or alcohol intake or due to certain medicines.

bannner image

Alcohol

Unsafe

Avoid consumption of alcohol with Etimark 0.25 Tablet as it may increase the risk of drowsiness and other adverse effects.

bannner image

Pregnancy

Caution

Etimark 0.25 Tablet is a Category C pregnancy drug, and safety is unknown. Please consult your doctor if you are pregnant or planning for pregnancy.

bannner image

Breast Feeding

Caution

It is unknown whether Etimark 0.25 Tablet is excreted in human milk. Please consult a doctor before using Etimark 0.25 Tablet while breastfeeding.

bannner image

Driving

Unsafe

Etimark 0.25 Tablet may cause dizziness, double vision or drowsiness in some people. Therefore, avoid driving if you feel drowsy, dizzy or experience any vision problems after taking Etimark 0.25 Tablet .

bannner image

Liver

Caution

Take Etimark 0.25 Tablet with caution, especially if you have a history of Liver diseases/conditions. The dose may be adjusted by your doctor as required.

bannner image

Kidney

Caution

If you have any concerns regarding the use of Etimark 0.25 Tablet in patients with kidney problems, please consult a doctor.

bannner image

Children

Caution

The safety of Etimark 0.25 Tablet in children is unknown. Please consult a doctor.

Country of origin

India

Manufacturer/Marketer address

Unimark Remedies Ltd. , 501/E-Wing,Skypark Chs Ltd,Oshiwara Garden Road, Next To Hdfc House, Off.S.V. Rpad, Goregaon (West), Mumbai- 400 104
Other Info - ETI0107

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Etimark 0.25 Tablet is used in the treatment of anxiety disorder, panic disorder and insomnia (difficulty in falling or staying asleep). It works by increasing the activity of GABA (a chemical messenger in the brain that acts as a natural nerve-calming agent) and is involved in inducing sleep.
No, you are not recommended to take Etimark 0.25 Tablet with opioids as co-administration of these medicines may cause breathing problems, drowsiness or other adverse effects. However, before using Etimark 0.25 Tablet with any other medicines, you are advised to contact your doctor so that the dosage may be adjusted accordingly to use safely.
Yes, Etimark 0.25 Tablet may cause drowsiness. Therefore, it is recommended to avoid driving or any other activities that require mental alertness after taking Etimark 0.25 Tablet .
No, you are not recommended to stop taking Etimark 0.25 Tablet without consulting your doctor as it may cause withdrawal symptoms such as palpitations (the sensation that heart skipped a beat or extra beat), anxiety, confusion, difficulty in sleeping and tremors. Therefore, take Etimark 0.25 Tablet for as long as your doctor has prescribed it, and if you experience any difficulty while taking Etimark 0.25 Tablet , please consult your doctor so that the dose may be gradually reduced.
Yes, Etimark 0.25 Tablet may cause mental or physical dependence if used for a prolonged time. Therefore, take Etimark 0.25 Tablet only in dose and duration as advised by your doctor.
No, Etimark 0.25 Tablet is not recommended for patients suffering from myasthenia gravis (severe muscle weakness) as it may worsen the condition. Therefore, inform your doctor if you have myasthenia gravis before taking Etimark 0.25 Tablet .

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.